Sensitization to Hymenoptera venoms is common, but systemic sting reactions are rare  Gunter J. Sturm, MD, PhD, Bettina Kranzelbinder, MD, Christian Schuster,

Slides:



Advertisements
Similar presentations
Joint modeling of parentally reported and physician-confirmed wheeze identifies children with persistent troublesome wheezing Danielle C.M. Belgrave, MSc,
Advertisements

Early exposure to cow's milk protein is protective against IgE-mediated cow's milk protein allergy Yitzhak Katz, MD, Nelly Rajuan, MSc, Michael R. Goldberg,
In situ imaging of honeybee (Apis mellifera) venom components from aqueous and aluminum hydroxide–adsorbed venom immunotherapy preparations Ulla Seppälä,
Peter Vadas, MD, PhD, Boris Perelman, PhD, Gary Liss, MD, MS 
Dose-time-response relationship in peanut allergy using a human model of passive cutaneous anaphylaxis  Anja P. Mose, MD, Charlotte G. Mortz, MD, PhD,
Repeated low-dose intradermal allergen injection suppresses allergen-induced cutaneous late responses  Giuseppina Rotiroti, MD, Mohamed Shamji, PhD, Stephen.
Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus.
Risk of an asthma exacerbation after bariatric surgery in adults
Kyoung-Bok Min, MD, PhD, Jin-Young Min, PhD 
Tolerant beekeepers display venom-specific functional IgG4 antibodies in the absence of specific IgE  Eva-Maria Varga, MD, Fahima Kausar, MSc, Werner.
Jay A. Lieberman, MD, Faith R. Huang, MD, Hugh A
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Increased soluble Fas ligand levels in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis preceding skin detachment  Junko Murata,
David A. Khan, MD  Journal of Allergy and Clinical Immunology 
Is 9 more than 2 also in allergic airway inflammation?
Advancing asthma care: The glass is only half full!
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J
Allergy testing in predicting outcome of open food challenge to peanut
Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus.
Physician needs in health informatics: Just ask the docs
A network-based analysis of the late-phase reaction of the skin
Elina Jerschow, MD, MSc, Robert Y. Lin, MD, MSc, Moira M
Peter M. Wolfgram, MD, David B. Allen, MD 
Etiology of asthma exacerbations
Jewlya Lynn, PhD, Sophie Oppenheimer, MS, MPH, Lorena Zimmer, MA 
Activin A is an acute allergen-responsive cytokine and provides a link to TGF-β– mediated airway remodeling in asthma  Christian Karagiannidis, MD, Gabriele.
Penicillin Skin Testing Is a Safe and Effective Tool for Evaluating Penicillin Allergy in the Pediatric Population  Stephanie J. Fox, MD, Miguel A. Park,
Intranasal triamcinolone use during pregnancy and the risk of adverse pregnancy outcomes  Anick Bérard, MSc, PhD, Odile Sheehy, MSc, Marie-Laure Kurzinger,
Phillip Lieberman, MD, Michael Tankersley, MD 
Tolerated wasp sting challenge improves health-related quality of life in patients allergic to wasp venom  Jörg Fischer, MD, Martin Teufel, MD, Alexandra.
Phillip Lieberman, MD, David Golden, MD 
Kerstin Bauermeister, MSc, Barbara K
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management  Scott H. Sicherer, MD, Hugh A. Sampson, MD  Journal.
Biosimilars and drug development in allergic and immunologic diseases
Myeloid and plasmacytoid dendritic cells in induced sputum after allergen inhalation in subjects with asthma  Benny Dua, MSc, Richard M. Watson, BSc,
Anaphylactic Reaction to White-Faced Hornet Sting and Elevated Baseline (Asymptomatic) Serum Tryptase  Phillip Lieberman, MD, Lawrence B. Schwartz, MD,
A cluster-randomized trial shows telephone peer coaching for parents reduces children's asthma morbidity  Jane M. Garbutt, MB, ChB, Yan Yan, MD, PhD,
Peter Vadas, MD, PhD, Boris Perelman, PhD, Gary Liss, MD, MS 
Lisa G. Wood, PhD, Manohar L. Garg, PhD, Peter G. Gibson, MBBS 
What is an “eosinophilic phenotype” of asthma?
Dose-time-response relationship in peanut allergy using a human model of passive cutaneous anaphylaxis  Anja P. Mose, MD, Charlotte G. Mortz, MD, PhD,
Skin test evaluation of a novel peptide carrier–based vaccine, BM32, in grass pollen– allergic patients  Verena Niederberger, MD, Katharina Marth, MD,
Cockroach allergens: Coping with challenging complexity
Autophagy: Nobel Prize 2016 and allergy and asthma research
The Editors' Choice Journal of Allergy and Clinical Immunology
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
Advances in the approach to the patient with food allergy
House dust mite sublingual immunotherapy: Results of a US trial
High prevalence of severe asthma in a large random population study
Is intralymphatic immunotherapy ready for clinical use in patients with grass pollen allergy?  Marianne Witten, MD, PhD, Hans-Jørgen Malling, MD, Lars.
Matthew J. Loza, PhD, Bao-Li Chang, PhD 
Protection by budesonide and fluticasone on allergen-induced airway responses after discontinuation of therapy  Padmaja Subbarao, MD, MSc, Sandra C. Dorman,
Spiking venom with rVes v 5 improves sensitivity of IgE detection in patients with allergy to Vespula venom  Byrthe Vos, Julian Köhler, Sabine Müller,
Risk of oral food challenges
Dose dependence and time course of the immunologic response to administration of standardized cat allergen extract  Anil Nanda, MD, Maeve O'Connor, MD,
Jessica H. Savage, MD, MHS, Elizabeth C. Matsui, MD, MHS, Robert A
The Editors' Choice Journal of Allergy and Clinical Immunology
Systemic and localized seminal plasma hypersensitivity patients exhibit divergent immunologic characteristics  Debajyoti Ghosh, PhD, Jonathan A. Bernstein,
Macrolide antibiotics and asthma treatment
Immune pathomechanism of drug hypersensitivity reactions
Statistical issues in clinical trials that involve the double-blind, placebo-controlled food challenge  Vernon M. Chinchilli, PhD, Laura Fisher, MD, Timothy.
Asthma: The past, future, environment, and costs
Repeated low-dose intradermal allergen injection suppresses allergen-induced cutaneous late responses  Giuseppina Rotiroti, MD, Mohamed Shamji, PhD, Stephen.
Hymenoptera venom protease allergens
Environmental factors and eosinophilic esophagitis
Efficacy of a short course of specific immunotherapy in patients with allergic rhinoconjunctivitis to ragweed pollen  Piyush Patel, MD, Tom Holdich, MBBS,
The GILL study: Glycerin-induced local reactions in immunotherapy
Systemic responses after bronchial aspirin challenge in sensitive patients with asthma  Joanna S. Makowska, MD, PhD, Janina Grzegorczyk, PhD, Barbara Bienkiewicz,
Food protein–induced enterocolitis syndrome: Not so rare after all!
Natural history of cow’s milk allergy
Presentation transcript:

Sensitization to Hymenoptera venoms is common, but systemic sting reactions are rare  Gunter J. Sturm, MD, PhD, Bettina Kranzelbinder, MD, Christian Schuster, MD, Eva M. Sturm, PhD, Danijela Bokanovic, MD, Jutta Vollmann, MSc, Karl Crailsheim, PhD, Wolfgang Hemmer, PhD, Werner Aberer, MD  Journal of Allergy and Clinical Immunology  Volume 133, Issue 6, Pages 1635-1643.e1 (June 2014) DOI: 10.1016/j.jaci.2013.10.046 Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Screening, sting challenges, and follow-up. Initially, 110 sensitized subjects consented to participate in the study. Control visits were optional, and therefore some subjects discontinued the study prematurely. Journal of Allergy and Clinical Immunology 2014 133, 1635-1643.e1DOI: (10.1016/j.jaci.2013.10.046) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Frequency of SSRs and LLRs compared with the general population. A, Although the frequency of SSRs was slightly higher in the study population, the difference to the general population was not statistically significant. B, Notably, the risk of LLRs was approximately 9.5-fold higher compared with the general population. Data of the general population were obtained by means of telephone survey of accidental stings.3 The study population was sensitized subjects undergoing deliberate sting challenges. n.s., Not significant. Journal of Allergy and Clinical Immunology 2014 133, 1635-1643.e1DOI: (10.1016/j.jaci.2013.10.046) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 3 Outcome of tests in subjects who tolerated sting challenges without SSRs. A, Positive test results in subjects who were stung by a bee. Skin tests and the BAT showed a lower rate of positive results. Because of the known low sensitivity of rApi m 1, the good correlation of rApi m 1 with the sting challenge should be viewed critically. B, Positive test results in subjects who were stung by a wasp. Importantly, even sIgE to the major wasp venom components was detectable in the majority of subjects. Journal of Allergy and Clinical Immunology 2014 133, 1635-1643.e1DOI: (10.1016/j.jaci.2013.10.046) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 4 Outcome of tests in subjects with and without LLRs. A, Positive test results in subjects who were stung by a bee. Unexpectedly, the frequency of positive test results in subjects with LLRs was mostly similar to that seen in those with no LLRs. Agreement of all test results with LLRs was weak (κ < 0.35). B, Positive test results in subjects who were stung by a wasp. Contrary to subjects having had bee stings, there was no difference in the sensitization rate between the tests. Only the BAT showed more positive results in subjects with LLRs. Similar to bee sensitizations, agreement of all test results with LLRs was weak (κ < 0.35). Journal of Allergy and Clinical Immunology 2014 133, 1635-1643.e1DOI: (10.1016/j.jaci.2013.10.046) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 5 Time course of sIgE levels after the sting. Generally, there was a slight but significant decrease in sIgE levels 3 hours after the sting in asymptomatic sensitized subjects (A, C, D). Only sIgE levels to Api m 1 remained stable (B). Of the reactors (E), 2 subjects showed a slight increase and 4 showed a slight decrease in sIgE levels (subjects 19 and 26 because of missing data for week 1 and 4 subjects not shown in Fig 5, E). In both nonreactors and reactors, sIgE levels markedly increased after only 1 week. Fig 5, A, n = 46 to 75; Fig 5, B, n = 26 to 28; Fig 5, C, n = 33 to 50; Fig 5, D, n = 22 to 24. Fig 5, E, Complete sIgE time course of 3 reactors. n.s., Not significant. Journal of Allergy and Clinical Immunology 2014 133, 1635-1643.e1DOI: (10.1016/j.jaci.2013.10.046) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 6 Outcome of repetitive sting challenges and correlation with test results. A, One year after the first sting challenge, more positive IDT and BAT results were observed. However, all repetitive sting challenges were tolerated without SSRs. B, The first sting challenge did not induce a significant increase in LLRs. C, Although CRD and IDTs revealed more positive results in subjects with LLRs, there was only a weak agreement between tests and the occurrence of LLRs (κ for all tests <0.35). Journal of Allergy and Clinical Immunology 2014 133, 1635-1643.e1DOI: (10.1016/j.jaci.2013.10.046) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 7 Time course of sIgE over a period of 2 years. A, sIgE levels to bee venom extract. After an initial marginal decrease directly after the first sting, sIgE levels increased to 5-fold of baseline. After 1 year, levels had decreased near baseline, increasing and decreasing again after the second challenge (n = 10-17). B, Normalized sIgE levels to bee and wasp venom extracts. Values are expressed as x-fold increase of baseline. Kinetics of sIgE were similar to those of quantitative levels. However, the increase in sIgE levels was only 2.1-fold after the second challenge compared with the 3.8-fold increase 1 week and 4.2-fold increase 4 weeks after the first challenge. (n = 10-19). C, Normalized levels of the major allergens Api m 1 and Ves v 5. The increase in sIgE levels to major allergens was slightly more pronounced compared with sIgE levels to the venom extracts. sIgE levels increased to 5.3-fold after 1 week and 5.6-fold after 4 weeks. After the second challenge, a modest increase to 2.6-fold was observed (n = 10-19). n.s., Not significant. Journal of Allergy and Clinical Immunology 2014 133, 1635-1643.e1DOI: (10.1016/j.jaci.2013.10.046) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions